MACM
GILD icon

March Altus Capital Management’s Gilead Sciences GILD Stock Holding History

March Altus Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17,162
Closed -$1.69M – 11
2015
Q3 		$1.69M Buy
+17,162
New +$1.91M 9.92% 2

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

March Altus Capital Management's GILD Position: Q4 2015 in Review

March Altus Capital Management sold out of Gilead Sciences (GILD) in Q4 2015, closing a stake of 17,162 shares — an estimated $1.69M sold.

March Altus Capital Management first reported a position in GILD in Q3 2015 and held it in 1 quarter. The position peaked at $1.69M in Q3 2015. 1,628 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • March Altus Capital Management reported no remaining Gilead Sciences position as of Q4 2015 after selling out during the quarter.
  • March Altus Capital Management sold 17,162 Gilead Sciences shares in Q4 2015, an estimated $1.69M.
  • March Altus Capital Management first reported a position in Gilead Sciences in Q3 2015 and held it in 1 quarter.
  • March Altus Capital Management's Gilead Sciences position peaked at $1.69M in Q3 2015.
  • 1,628 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on March Altus Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.